New One-Hour blood test could speed up heart attack diagnosis

NCT ID NCT03507270

Completed Diagnosis Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new one-hour diagnostic algorithm using a protein called FABP to quickly confirm or rule out a type of heart attack called NSTEMI. It involved 20 male patients who arrived at the hospital within 4 hours of chest pain. The goal was to see if measuring FABP levels could help doctors make faster decisions about treatment and hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fatty-acid-binding protein (FABP) diagnostic test
What this could lead to: If successful, this could lead to a faster, more accurate way to diagnose non-ST elevation heart attacks within one hour, helping doctors decide on treatment sooner.
What could go wrong: This is a very small pilot study with only 20 male participants, so results may not apply to women or larger populations. The test's accuracy is still uncertain and needs more research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute subendocardial myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

Contacts and locations

Locations

Cardiology Research Institute, Tomsk NRMC

Tomsk, 634012, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.